Modified Release Dosage Form

Abstract: A modified release dosage form comprising of a highly soluble salt of HMG-CoA reductase inhibitor fluvastatin, which utilizes dual retard technique to effectively reduce the quantitiy of release controlling agents; a process for preparing the dosage form.

Patent Information

Applicants

Inventors

Specification

Documents